Kong Wei-Ya, Zhao Sheng-Rui, Deng Ke, Zhang Qin, Liu Wei, Yan Lei
School of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.
Eur J Obstet Gynecol Reprod Biol. 2021 Mar;258:132-138. doi: 10.1016/j.ejogrb.2020.12.046. Epub 2020 Dec 29.
A bicornuate uterus results from failure of the Müllerian ducts to completely fuse. If patients with bicornuate uterus are diagnosed with infertility, they can conceive with help from in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI). With few studies on the reproductive performances of bicornuate uterus following IVF/ICSI treatment, the aim of present study is to investigate whether a bicornuate uterus would affect pregnancy rates and obstetric outcomes of infertile women.
A retrospective cohort study contained 232 women (58 with bicornuate uterus and 174 with normal uterus) was conducted. Patient data for IVF/ICSI treatment and follow-up were collected and analyzed. Cumulative pregnancy rate and cumulative live birth rate after one complete assisted reproductive technology (ART) cycle were the primary outcomes.
Baseline characteristics were comparable between the bicornuate uterus group and the control group. Ovarian response to stimulation and embryological results were similar between the two groups. In fresh embryo transfer cycles, embryo implantation rate (32.7 % vs. 42.9 %, P = 0.176), biochemical pregnancy rate (54.1 % vs. 64.9 %, P = 0.236), and clinical pregnancy rate (45.9 % vs. 58.8 %, P = 0.172) did not differ significantly between the bicornuate uterus group and the control group. Live birth rate (40.5 % vs. 43.9 %, P = 0.723), term delivery rate (93.3 % vs. 90.0 %, P = 0.696), cesarean section rate (73.3 % vs. 76.0 %, P = 0.833), and newborn birth weight (3.35 ± 0.56 vs. 3.32 ± 0.51, P = 0.524) also did not differ significantly between the two groups. In frozen-thawed embryo transfer cycles, there were no significant differences in outcomes between the two groups. Upon completion of one IVF/ICSI cycle, cumulative pregnancy rate (59.6 % vs. 71.0 %, P = 0.112) and cumulative live birth rate (58.2 % vs. 64.8 %, P = 0.375) were similar between the two groups.
There were no significant differences in ovarian responses, pregnancy outcomes, and obstetric outcomes after IVF/ICSI treatment between women with bicornuate uterus and women with normal uterus. Bicornuate uterus had no significant negative effects on cumulative IVF/ICSI outcomes of infertile patients.
双角子宫是由于苗勒管未能完全融合所致。双角子宫患者若被诊断为不孕症,可借助体外受精/卵胞浆内单精子注射(IVF/ICSI)技术受孕。鉴于针对IVF/ICSI治疗后双角子宫患者生殖表现的研究较少,本研究旨在探讨双角子宫是否会影响不孕女性的妊娠率和产科结局。
进行了一项回顾性队列研究,纳入232名女性(58名双角子宫患者和174名子宫正常的患者)。收集并分析了IVF/ICSI治疗及随访的患者数据。一个完整辅助生殖技术(ART)周期后的累积妊娠率和累积活产率为主要结局指标。
双角子宫组与对照组的基线特征具有可比性。两组的卵巢刺激反应和胚胎学结果相似。在新鲜胚胎移植周期中,双角子宫组与对照组的胚胎着床率(32.7%对42.9%,P = 0.176)、生化妊娠率(54.1%对64.9%,P = 0.236)和临床妊娠率(45.9%对58.8%,P = 0.172)差异均无统计学意义。两组的活产率(40.5%对43.9%,P = 0.723)、足月分娩率(93.3%对90.0%,P = 0.696)、剖宫产率(73.3%对76.0%,P = 0.833)及新生儿出生体重(3.35±0.56对3.32±0.51,P = 0.524)差异也均无统计学意义。在冻融胚胎移植周期中,两组的结局差异无统计学意义。完成一个IVF/ICSI周期后,两组的累积妊娠率(59.6%对71.0%,P = 0.112)和累积活产率(58.2%对64.8%,P = 0.375)相似。
双角子宫女性与子宫正常女性在IVF/ICSI治疗后的卵巢反应、妊娠结局和产科结局方面差异均无统计学意义。双角子宫对不孕患者IVF/ICSI的累积结局无显著负面影响。